Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Value of IFNL3 genetic polymorphism in the prediction of HCV treatment response to direct-acting antiviral drugs versus interferon therapy
- Ghanem S.E. , et al.
2. Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: Systematic review and meta-analysis
- Cariani E. , et al.
3. IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors
- Olmedo D. , et al.
4. PharmGKB summary: Peginterferon-á pathway
- Shuldiner S.R. , et al.
5. Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients
- Dzekova-Vidimliski P. , et al.
6. Characterization of the interleukin-28B gene rs12979860 C/T polymorphism in Turkish chronic hepatitis C patients and healthy individuals
- Taheri S. , et al.
7. Interleukin-28b (rs12979860) gene variation and treatment outcome after peginterferon plus ribavirin therapy in patients with genotype 1 of hepatitis C virus
- Kalantari H. , et al.
9. The role of pharmacogenetics in the treatment of chronic hepatitis C infection
- Kawaguchi-Suzuki M. , et al.
10. The influence of single and combined IL28B polymorphisms on response to treatment of chronic hepatitis C
- Lazarevic I. , et al.
11. Meta-analysis: Implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
- Jiménez-Sousa M.A. , et al.